Correction to: Lessons learned from phase 3 trials of immunotherapy for glioblastoma: Time for longitudinal sampling? is a research paper published in Neuro-Oncology (2023). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: P01 CA163205
National Cancer Institute
Grant: P01 CA236749
National Institutes of Health
Grant: R01NS110942
National Institutes of Health
Grant: 2T32CA079443
NCI NIH HHS
Grant: T32 CA079443
The Daniel E. Ponton Fund
The Sandra Jelin Plouffe Fund to Advance Glioblastoma Research
Alliance for Cancer Gene Therapy
The Oligodendroglioma Fund
The MIT Koch Institute Bridge Grant
Fields of Study
Keywords
Sustainable Development Goals